Yes. I cannot talk about all of them, but I think some of the comments come about from the situation where we are requiring, as a department, additional information from the prescribing physician as to why he or she is going with this prescription. It goes back to the CADTH recommendation that says, okay, this product should be used as a second-line or third-line therapy or should only be used if there is an allergy to that kind of product.
As a payer, our responsibility is to go back to the physician and say, “We have received that script to be paid by that pharmacy. Could you please confirm the reason you went with this product? Is it because the person has already tried the first-line or second-line therapy, or is there an allergy element?” There are criteria and we ask the physician to answer these kinds of questions.